Gabelli Healthcare & Wellness Trust:GRX

    Manage Alerts

    Overview

    As of 12/20/2024. NAV as of 12/19/2024.

     Share
    Price
    NAVPremium/
    Discount
    Current$9.65$10.93-12.53%
    52 Wk Avg$10.05$11.93-15.78%
    52 Wk High$11.24$12.91-10.39%
    52 Wk Low$9.03$10.93-19.71%
    Regular Distribution TypeIncome Only
    Distribution Rate6.22%
    Distribution Amount$0.1500
    Distribution FrequencyQuarterly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    The Fund's investment objective is long term growth of capital. The Fund will invest at least 80% of its assets, under normal market conditions, in equity securities and income producing securities of domestic and foreign companies in the healthcare and wellness industries.

    Capital Structure

    As of 12/20/2024

    Total Investment Exposure:$225.149M
    Total Common Assets:$170.464M
    Common Shares Outstanding:15,595,983
    Leverage

    As of 12/19/2024

    Preferred Share Assets: $24.320M
    Total Debt (USD): $30.365M
    Regulatory Leverage (USD): $54.685M
    Effective Leverage (USD): $54.685M
    Effective Leverage (%): 24.29%
    Annual Expense Ratios

    As of 12/31/2023

      Per Common Share
    Management FeesN/A
    Other Expenses:N/A
    Baseline Expense: N/A
    Interest Expense:N/A
    Total: 3.18%
    Fund Management

    Fund Sponsor
    Gabelli

    Portfolio Managers
    Kevin V. Dreyer, Jeffrey J. Jonas, Jennie Tsai, Sara Wojda, Mario J. Gabelli

    Basics
    Category: Equity-Sector Equity
    Ticker: GRX
    NAV Ticker: XXGRX
    Average Daily Volume (shares): 32,735
    Average Daily Volume (USD): $0.326M
    Inception Date: 6/19/2007
    Inception Share Price: $8.00
    Inception NAV: $8.00
    Tender Offer: No
    Term: No
    Fiscal Year End: December 31
    Third Party Links & Reports

    Distributions

    As of 12/20/2024

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 6/30/2024
    -$0.0633
    Annualized Distribution Rate on NAV:
    As of 12/20/2024
    5.49%
    Total Return on NAV (12 months):
    As of 12/20/2024
    17.06%
    Total % Portfolio Effectively Leveraged:
    As of 12/20/2024
    24.29%

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 12/20/2024

    PeriodAvg Discount
    6 Month-13.52%
    1 Year-15.78%
    3 Year-15.21%
    5 Year-14.67%
    Z-Score

    As of 12/20/2024

    PeriodZStat
    3 Month0.85
    6 Month1.29
    1 Year1.60
    Pricing History
    Date NAV Premium / Discount

    Performance

    Calendar Year Total Returns

    As of 11/30/2024
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    YTD16.68%7.85%34.33%19.16%
    2023-3.31%1.56%4.81%6.23%
    2022-19.96%-17.98%-10.73%-7.15%
    202122.01%18.47%22.39%17.58%
    202010.04%10.82%5.15%5.71%
    201931.28%25.21%26.64%22.38%
    2018-5.75%-2.74%-12.35%-9.96%
    201715.05%13.11%18.18%12.88%
    2016-3.07%-3.63%17.45%14.67%
    20153.21%4.55%-15.98%-12.75%
    201410.16%16.63%5.16%4.65%
    201331.67%28.70%16.34%17.44%
    201236.80%25.37%12.53%11.75%
    201113.33%17.51%  
    20105.97%9.15%  
    200933.73%24.96%  
    2008-28.55%-22.03%  
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 11/30/2024
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Number of Holdings:
    As of 9/30/2024
    138
    Annual Portfolio Turnover:
    As of 12/31/2023
    21.00%
    Asset Allocation

    As of 9/30/2024

    Top Sectors

    As of 9/30/2024

    Sector%Portfolio
    Defensive (Super Sector)96.93%
    Healthcare68.18%
    Consumer Defensive28.75%
    Government2.37%
    Government (Super Sector)2.37%
    Industrials0.61%
    Sensitive (Super Sector)0.61%
    Corporate (Super Sector)0.06%
    Preferred Stock0.06%
    Consumer Cyclical0.02%
    Top Holdings

    As of 9/30/2024

    HoldingValue% Portfolio
    AbbVie Inc$9.28M3.69%
    Tenet Healthcare Corp$8.09M3.22%
    Johnson & Johnson$7.11M2.83%
    The Cigna Group$6.72M2.67%
    BellRing Brands Inc Class A$6.38M2.54%
    HCA Healthcare Inc$6.22M2.47%
    Evolent Health Inc Class A$6.04M2.40%
    Elevance Health Inc$5.82M2.32%
    Catalent Inc$5.15M2.05%
    Option Care Health Inc$5.09M2.02%
    Credit Quality

    As of 9/30/2024

    Country Allocation

    As of 9/30/2024

    Country% Portfolio
    United States - Equity84.77%
    Japan - Equity4.17%
    United Kingdom - Equity2.67%
    Switzerland - Equity1.62%
    Ireland - Equity1.33%
    Canada - Equity1.12%
    France - Equity0.77%
    Israel - Equity0.75%
    Hong Kong - Equity0.18%
    Germany - Equity0.12%
    China - Equity0.07%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.

    NOTES:

    Distribution type sourced from Morningstar. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.

    E-2949862P-E0623W